APGE
Apogee Therapeutics, Inc. Common StockNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$6.12B
P/E Ratio
—
EPS
$-4.33
Beta
0.69
52W High
$95.31
52W Low
$34.34
50-Day MA
$82.03
200-Day MA
$65.10
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About Apogee Therapeutics, Inc. Common Stock
Apogee Therapeutics, Inc., through its subsidiary, is a biotechnology company that develops biologics for the treatment of atopic dermatitis (AD), chronic obstructive pulmonary disease (COPD), and related inflammatory and immunology indications. The company is headquartered in Waltham, Massachusetts.
Fundamentals
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | 0 |
| EBITDA | $-303.65M |
| Operating Margin | 0.00% |
| Return on Equity | -28.50% |
| Return on Assets | -19.00% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $16.87 |
| Price-to-Book | 4.87 |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | — |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | $61.90M |
| Float | $57.84M |
| % Insiders | 9.68% |
| % Institutions | 131.01% |
Historical Volatility
HV 10-Day
36.78%
HV 20-Day
36.57%
HV 30-Day
33.59%
HV 60-Day
56.98%
HV Rank
6.0%
Volatility is currently expanding
Analyst Ratings
Consensus ($119.69 target)
14
Buy3
HoldMore HEALTHCARE Stocks
Data last updated: 5/25/2026